Lexaria Bioscience Corp.
LEXX | NASDAQ
$3.38
-$0.04 (-1.17%)
Sep 22, 2026, 1:00 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 May 30, 2026 | Q2 2026 Feb 27, 2026 | Q1 2026 Nov 29, 2025 | Q4 2025 Aug 30, 2025 | Q3 2025 May 30, 2025 | Q2 2025 Feb 27, 2025 | Q1 2025 Nov 29, 2024 | Q4 2024 Aug 30, 2024 | Q3 2024 May 30, 2024 | Q2 2024 Feb 28, 2024 | Q1 2024 Nov 29, 2023 | Q4 2023 Aug 30, 2023 | Q3 2023 May 30, 2023 | Q2 2023 Feb 27, 2023 | Q1 2023 Nov 29, 2022 | Q4 2022 Aug 30, 2022 | Q3 2022 May 30, 2022 | Q2 2022 Feb 27, 2022 | Q1 2022 Nov 29, 2021 | Q4 2021 Aug 30, 2021 | Q3 2021 May 30, 2021 | Q2 2021 Feb 27, 2021 | Q1 2021 Nov 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.99M | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.32M | -2.57M | 415.19K | -710.12K |
Depreciation & Amortization | 19.21K | 19.1K | 16.87K | 21.4K | 30.96K | 2.28K | 33.2K | -7.76K | 15.07K | 15.93K | 28.78K | 70.93K | 25.01K | 24.73K | 24.73K | 63.33K | 23.89K | 26.16K | 27.93K | 63.81K | 27.93K | 27.93K | 27.93K |
Stock-Based Compensation | 92.94K | 74.9K | 74.9K | 122.72K | 470.14K | 167.22K | 99.42K | 96.51K | 341.77K | n/a | 53.95K | 9.63K | 81.45K | 10.53K | 68.78K | 232.87K | 111.17K | n/a | 408.54K | n/a | 343.97K | 17.15K | 48.89K |
Other Working Capital | -368.48K | -860.42K | 219.31K | -313.7K | -317.12K | 1.1M | -58.69K | 127.92K | -48.24K | -196.06K | 273.5K | 71.75K | -327.64K | -75.37K | 316.42K | -419.45K | 64.65K | 15.26K | 76.81K | -118.13K | -13.18K | -142.61K | 65.81K |
Other Non-Cash Items | 453.49K | 9.27K | 22.02K | 234.54K | 49.64K | 17.85K | 16.12K | 32.03K | 85.06K | 26.54K | 55.2K | 261.63K | 11.1K | 22.14K | 77.37K | 505.12K | 853.39K | 252.11K | 351.26K | 159.19K | 866.7K | -1.44M | -1.74K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -207.68K | -814.41K | 499.62K | -323.93K | -344.08K | 1.03M | -168.14K | 174.13K | 76.32K | -9.35K | -134.55K | -714.85K | 480.04K | 24.96K | 353.11K | -464.78K | 170.75K | -106.87K | 49.43K | 22.44K | 171.25K | 71.12K | -174.49K |
Operating Cash Flow | -1.64M | -2.16M | -984.1K | -2.64M | -3.58M | -1.5M | -2.73M | -1.89M | -1.27M | -619.61K | -1.18M | -1.62M | -1.79M | -1.23M | -1.25M | -1.18M | -1.26M | -1.28M | -1.17M | -1.08M | -1.16M | -911.25K | -809.53K |
Capital Expenditures | n/a | -55.91K | -5.1K | -14.61K | -19.44K | -27.89K | -37.8K | -69.59K | -22K | -56.99K | -40.03K | -68.44K | -33.65K | -32.68K | -34.84K | -50.04K | -37.96K | -34.42K | -58.22K | -3 | -70.73K | -2.99K | -5.78K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2 | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -837 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -26.25K | -13.09K | n/a | -157.88K | -19.44K | -27.89K | -13.16K | -26.57K | n/a | n/a | n/a | n/a | n/a | -19.44K | -14.34K | -4 | -31.14K | n/a | -15.84K | n/a | n/a | 273.38K | n/a |
Investing Cash Flow | -27.09K | -53.91K | -5.1K | -157.88K | -19.44K | -27.89K | -37.8K | -69.59K | -22K | -56.99K | -40.03K | -68.44K | -33.65K | -32.68K | -34.84K | -50.05K | -37.96K | -34.42K | -58.22K | -2 | -70.73K | 270.38K | -5.78K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.2K | -11.2K | -11.21K | -11.2K | -11.2K | -10.99K | 419 | -10.99K | -23.16K | -8.77K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.04M | 491.82K | 571.65K | n/a | n/a | -11.2K | 11.2K | n/a | n/a | n/a | n/a | -43.95K | n/a | n/a | n/a |
Financial Cash Flow | n/a | 3.04M | 3.47M | n/a | 1.69M | 11.72K | 4.35M | n/a | 5.04M | 3.45M | 1.82M | -121.69K | 1.71M | n/a | n/a | -11.21K | -11.2K | -11.2K | -10.99K | 3.97M | -10.99K | 9.44M | -8.77K |
Net Cash Flow | -1.65M | 846.91K | 2.48M | -2.79M | -1.88M | -1.61M | 1.58M | -1.96M | 3.75M | 2.75M | 602.06K | -1.81M | -108.2K | -1.26M | -1.28M | -1.24M | -1.31M | -1.32M | -1.24M | 2.81M | -1.24M | 8.82M | -768.41K |
Free Cash Flow | -1.64M | -2.22M | -989.2K | -2.66M | -3.6M | -1.53M | -2.76M | -1.96M | -1.29M | -676.6K | -1.22M | -1.69M | -1.82M | -1.26M | -1.28M | -1.23M | -1.3M | -1.31M | -1.22M | -1.08M | -1.23M | -914.24K | -815.31K |
Adj. Free Cash Flow | -1.73M | -2.29M | -1.06M | -2.78M | -4.07M | -1.69M | -2.86M | -2.06M | -1.63M | -676.6K | -1.28M | -1.7M | -1.9M | -1.27M | -1.35M | -1.46M | -1.41M | -1.31M | -1.63M | -1.08M | -1.57M | -931.39K | -864.2K |
Maintenance CapEx | n/a | -19.1K | -5.1K | n/a | n/a | n/a | -3.05K | n/a | -15.4K | n/a | n/a | -68.44K | -33.65K | -32.68K | n/a | n/a | -37.96K | -34.42K | -58.22K | -3 | n/a | n/a | n/a |
Growth CapEx | n/a | -36.81K | n/a | -14.61K | -19.44K | -27.89K | -34.76K | -69.59K | -6.6K | -56.99K | -40.03K | n/a | n/a | n/a | -34.84K | -50.04K | n/a | n/a | n/a | n/a | -70.73K | -2.99K | -5.78K |
Owner Earnings | -1.64M | -2.18M | -989.2K | -2.64M | -3.58M | -1.5M | -2.73M | -1.89M | -1.28M | -619.61K | -1.18M | -1.69M | -1.82M | -1.26M | -1.25M | -1.18M | -1.3M | -1.31M | -1.22M | -1.08M | -1.16M | -911.25K | -809.53K |
Add to Watchlist
Select watchlists to add or remove LEXX